Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus

Gut

Volumn 60, Issue 5, 2011, Pages 638-647

  Tsuchida, Yasuaki ^a,b   Hatao, Fumihiko ^b   Fujisawa, Masahiko ^c   Murata, Takahisa ^a   Kaminishi, Michio ^b   Seto, Yasuyuki ^b   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; CJ 033466; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYLLYCACONITINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MOSAPRIDE CITRATE; SEROTONIN 4 AGONIST; SEROTONIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG POTENCY; ILEUS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTESTINAL DYSMOTILITY; INTESTINE MUSCLE; INTESTINE SURGERY; INTESTINE TRANSIT TIME; MACROPHAGE; MALE; MONOCYTE; NERVE CELL STIMULATION; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE CONTRACTILITY;

AMINOPYRIDINES; ANIMALS; BENZAMIDES; CHOLINERGIC FIBERS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL TRANSIT; ILEUM; ILEUS; IMIDAZOLES; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MORPHOLINES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; NEUTROPHIL INFILTRATION; POSTOPERATIVE COMPLICATIONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN 5-HT4 RECEPTOR AGONISTS; TISSUE CULTURE TECHNIQUES;

EID: 79953759049     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.227546     Document Type: Article

References (56)

1. Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991;36:616-20.
2. Appel-Dingemanse S. Clinical pharmacokinetics of tegaserod, a serotonin 5-HT4 receptor partial agonist with promotile activity. Clin Pharmacokinet 2002;41:1021-42. (Pubitemid 35246780)
3. Deruyttere M, Lepoutre L, Heylen H, et al. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clin Ther 1987;10:44-51. (Pubitemid 18085042)
4. Kim HS, Choi EJ, Park H. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro. Neurogastroenterol Motil 2008;20:169-76.
5. Cellek S, John AK, Thangiah R, et al. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 2006;18:853-61. (Pubitemid 44201172)
6. Baker DE. Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health Syst Pharm 2005;62:700-11; quiz 12-13.
7. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397-414. (Pubitemid 46127672)
8. Liu M, Geddis MS, Wen Y, et al. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2005;289: G1148-63.
9. Poole DP, Xu B, Koh SL, et al. Identification of neurons that express 5- hydroxytryptamine 4 receptors in intestine. Cell Tissue Res 2006;325:413-22. (Pubitemid 44126156)
10. Prins NH, Akkermans LM, Lefebvre RA, et al. 5-HT4 receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. Br J Pharmacol 2000;131:927-32.
11. Livingston EH, Passaro EP Jr. Postoperative ileus. Dig Dis Sci 1990;35:121-32. (Pubitemid 20024258)
12. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004;16(Suppl 2):54-60. (Pubitemid 39468867)
13. Boeckxstaens GE, Pelckmans PA, Rampart M, et al. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction. J Pharmacol Exp Ther 1990;254:652-8. (Pubitemid 20262109)
14. De Winter BY, Boeckxstaens GE, De Man JG, et al. Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol 1997;120:464-8. (Pubitemid 27052844)
15. Kalff JC, Carlos TM, Schraut WH, et al. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999;117:378-87. (Pubitemid 29352946)
16. Kalff JC, Schraut WH, Billiar TR, et al. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 2000;118:316-27. (Pubitemid 30067505)
17. Schwarz NT, Kalff JC, Turler A, et al. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 2001;121:1354-71. (Pubitemid 33140453)
18. Wehner S, Behrendt FF, Lyutenski BN, et al. Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 2007;56:176-85.
19. Schmidt J, Stoffels B, Moore BA, et al. Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus. Gastroenterology 2008;135:926-36 e1-2.
20. Mikkelsen HB, Thuneberg L, Rumessen JJ, et al. Macrophage-like cells in the muscularis externa of mouse small intestine. Anat Rec 1985;213:77-86. (Pubitemid 16255617)
21. Ozaki H, Kawai T, Shuttleworth CW, et al. Isolation and characterization of resident macrophages from the smooth muscle layers of murine small intestine. Neurogastroenterol Motil 2004;16:39-51. (Pubitemid 38253521)
22. Mikkelsen HB, Rumessen JJ. Characterization of macrophage-like cells in the external layers of human small and large intestine. Cell Tissue Res 1992;270:273-9.
23. Kinoshita K, Horiguchi K, Fujisawa M, et al. Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis. Histochem Cell Biol 2007;127:41-53. (Pubitemid 46011321)
24. Hori M, Kita M, Torihashi S, et al. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol Gastrointest Liver Physiol 2001;280:G930-8.
25. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg 2000;87:1480-93.
26. Seta ML, Kale-Pradhan PB. Efficacy of metoclopramide in postoperative ileus after exploratory laparotomy. Pharmacotherapy 2001;21:1181-6. (Pubitemid 32939091)
27. Sanger GJ. 5-Hydroxytryptamine and the gastrointestinal tract: where next? Trends Pharmacol Sci 2008;29:465-71.
28. Zeinali F, Stulberg JJ, Delaney CP. Pharmacological management of postoperative ileus. Can J Surg 2009;52:153-7.
29. De Winter BY, Boeckxstaens GE, De Man JG, et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut 1999;45:713-18. (Pubitemid 29492144)
30. Narita K, Tsunoda A, Takenaka K, et al. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma. Dis Colon Rectum 2008;51:1692-5.
31. de Jonge WJ, Ulloa L. The a7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007;151:915-29. (Pubitemid 47195518)
32. Sakashita M, Mizuki Y, Hashizume T, et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. Arzneimittelforschung 1993;43:859-63. (Pubitemid 23254934)
33. Yoshida N, Omoya H, Kato S, et al. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittelforschung 1993;43:1078-83. (Pubitemid 23311886)
34. Mikami T, Ochi Y, Suzuki K, et al. 5-Amino-6-chloro-N-[(1- isobutylpiperidin-4-yl) methyl]-2-methylimidazo[1,2-α]pyridine-8- carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine 4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. J Pharmacol Exp Ther 2008;325:190-9.
35. Toga T, Kohmura Y, Kawatsu R. The 5-HT4 agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities. J Pharmacol Sci 2007;105:207-10. (Pubitemid 350106811)
36. Grossman CJ, Kilpatrick GJ, Bunce KT. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol 1993;109:618-24. (Pubitemid 23181036)
37. Idzko M, Panther E, Stratz C, et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 2004;172:6011-19. (Pubitemid 38621202)
38. Tanila H, Kauppila T, Taira T. Inhibition of intestinal motility and reversal of postlaparotomy ileus by selective α2-adrenergic drugs in the rat. Gastroenterology 1993;104:819-24. (Pubitemid 23059581)
39. Kreiss C, Toegel S, Bauer AJ. α2-Adrenergic regulation of NO production alters postoperative intestinal smooth muscle dysfunction in rodents. Am J Physiol Gastrointest Liver Physiol 2004;287:G658-66.
40. Brown SW, Meyers RT, Brennan KM, et al. Catecholamines in a macrophage cell line. J Neuroimmunol 2003;135:47-55. (Pubitemid 36170150)
41. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62. (Pubitemid 30367422)
42. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003;421:384-8. (Pubitemid 36157937)
43. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006;131:1122-30. (Pubitemid 44498700)
44. The FO, Boeckxstaens GE, Snoek SA, et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007;133:1219-28.
45. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6:844-51.
46. 125I-α-conotoxin ArIB[V11L;V16A], a selective α7 nicotinic acetylcholine receptor antagonist. J Pharmacol Exp Ther 2008;325:911-19.
47. Hori M, Nobe H, Horiguchi K, et al. MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation. Am J Physiol Cell Physiol 2008;294:C391-401.
48. Schwarz NT, Beer-Stolz D, Simmons RL, et al. Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. Ann Surg 2002;235:31-40. (Pubitemid 34062397)
49. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-64. (Pubitemid 41746764)
50. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009;21:6-17.
51. Chernyavsky AI, Arredondo J, Skok M, et al. Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. Int Immunopharmacol 2010;10:308-15.
52. Su X, Lee JW, Matthay ZA, et al. Activation of the α7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol 2007;37:186-92. (Pubitemid 47255001)
53. Davies BD, Hoss W, Lin JP, et al. Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol Cell Biochem 1982;44:23-31. (Pubitemid 12087076)
54. Saeed RW, Varma S, Peng-Nemeroff T, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005;201:1113-23. (Pubitemid 40524679)
55. de Jonge WJ, The FO, van der Coelen D, et al. Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 2004;127:535-45.
56. Mishra NC, Rir-sima-ah J, Boyd RT, et al. Nicotine inhibits FcvarepsilonRI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through α7/α9/α10-nicotinic receptors. J Immunol 2010;185:588-96.